Open original FDA record ↗Recall record
- FDA identifier
- Z-0174-2012
- Company in FDA record
- Becton Dickinson & Company
- FDA classification date
- Nov 7, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Experiment labels may be on shelf cartons of 1.0ml 28G x 1/2 blister packaged insulin syringes.
Source facts
- Action
- The firm, BD, sent an "PRODUCT RECALL NOTIFICATION" letter and response form dated June 15, 2011 to their consignee/customers. The letter describes the product, problem and actions to be taken. The customers were instructed to immediately review their inventory for the affected product, remove the product from inventory, quarantine the product and return it to BD; if the product was further distributed, they should identify their customers and notify them at once, and complete and return the attached Tracking/Verification Form via fax to: 201-847-4853. If you have any questions, contact Customer Service at 1-800-237-2762, Monday -Thursday, 8:00am-6:30pm and on Friday, 8:00-5:30pm Eastern Standard Time.
- Initiated
- 2011-06-15
- Root cause
- Labeling mix-ups
- Terminated
- 2015-07-27
- Distribution
- Nationwide Distribution.
- Recall number
- Z-0174-2012
- Recall status
- Terminated
- CDRH record ID
- 104880
- FDA classified
- 2011-11-07
- Recall event number
- 60255